Antibacterial Screening of some Heterocyclic Compounds Containing Quinoline Nucleus

[4] M.P. Maguire et al., A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives, J. Med. Chem. 37(14) (1994) 2129-2137.

[5] B. Kalluraya, S. Sreenivasa, Synthesis and pharmacological properties of some quinoline derivatives, IL Farmaco. 53(6) (1998) 399-404.

[6] G. Roma et al., 1, 8-Naphthyridines IV. 9-Substituted N, N-dialkyl-5-(alkylamino or cycloalkylamino) [1, 2, 4]triazolo[4, 3-a] [1, 8] naphthyridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inflammatory activities, Eur. J. Med. Chem. 35(11) (2000).

[7] Y.L. Chen et al., Synthesis and antibacterial evaluation of certain quinolone derivatives, J. Med. Chem. 44(14) (2001) 2374-2377.

[8] M.M. Ghorabi, M.S. Bashandy, M. S Alsaid, Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents, Acta Pharm. 64(4) (2014) 419-431.

[9] X. Zhang, A.S. Shetty, S.A. Jenekhe, Electroluminescence and photophysical properties of polyquinolines, Macromolecules. 32(22) (1999) 7422-7429.

[10] S.A. Jenekhe, L. Lu, M.M. Alam, New conjugated polymers with donor−acceptor architectures:  synthesis and photophysics of carbazole−quinoline and phenothiazine −quinoline copolymers and oligomers exhibiting large intramolecular charge transfer, Macromolecules. 34(21) (2001).

[11] A. Marella et al., Quinoline: A versatile heterocyclic, Saudi Pharma. J. 21(1) (2013) 1-12.

[12] S. Kumar, S. Bawa, H. Gupta, Biological activities of quinoline derivatives, Mini Rev. Med. Chem. 9(14) (2009) 1648-1654.

[13] K.R.A. Abdellatif et al., Design, synthesis and biological evaluation of new 4-(4-substituted-anilino) quinoline derivatives as anticancer agents, Med. Chem. Res. 26(5) (2017) 929–939.

[14] B.C. Revanasiddappa et al., Synthesis and biological studies of some novel schiff bases and hydrazones derived from 8-hydroxy quinoline moiety, Int. J. Chem. Tech. Res. 1 (2009) 1100-1104.

[15] Z.G. Luo et al., Synthesis and biological activities of quinoline derivatives as HIV-1 integrase inhibitors, Chem. Res. Chin. Univ. 25 (2009) 841-845.

[16] S. Vandekerckhove, M. D'hooghe, Quinoline-based antimalarial hybrid compounds, Bioorg. Med. Chem. 23(16) (2015) 5098-5119.

[17] X.F. Zhu et al., Synthesis and structure-activity relationships study of α-aminophosphonate derivatives containing a quinoline moiety, Chin. Chem. Lett. 28(7) (2017) 1514-1518.

[18] S. Kirankumar et al., New efficient synthesis of 3-carboxylquinolines, J. Korean Chem. Soc. 56(3) (2012) 322-327.

[19] X. Franck et al., Biological evaluation of substituted quinolones, Bioorg. Med. Chem. Lett. 14(14) (2004) 3635-3638.

[20] H. Amii, Y. Kishikawa, K. Uneyama, Rh(I)-catalyzed coupling cyclization of n-aryl trifluoroacetimidoyl chlorides with alkynes:  one-pot synthesis of fluorinated quinolones, Org. Lett. 3(8) (2001) 1109-1112.

[21] T. Igarashi et al., One-pot synthesis of substituted quinolines by Iridium-catalyzed three-component coupling reaction, Chem. Lett. 34(1) (2005) 106-107.

[22] N. Sakai et al., Yb(OTf)3-catalyzed cyclization of an N-silylenamine with 2-methylene-1, 3-cyclohexanedione to afford a 7, 8-dihydroquinolin-5(6H)-one derivative and its application to the one-pot conversion to a 2, 3, 5-trisubstituted quinoline derivative, Tetrahedron Lett. 47(8) (2006).

[23] K.D. Thomas, A.V. Adhikari, N.S. Shetty, Design, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1, 2, 3-triazole moiety, Eur. J. Med. Chem. 45(9) (2010) 3803-3810.

[24] V.V. Kouznetsov, L.Y. Me´ndez, C.M.M. Gómez, Recent progress in the synthesis of quinolines, Curr. Org. Chem. 9(2) (2005) 141-161.

[25] A. Lilienkampf et al., Structure−activity relationships for a series of quinoline-based compounds active against replicating and non replicating Mycobacterium tuberculosis, J. Med. Chem. 52(7) (2009) 2109–2118.

[26] Q. Guo et al., Synthesis of quinoline derivatives from anilines and aldehydes catalyzed by Cp2ZrCl2 and recyclable Cp2ZrCl2/MCM-41 system, Catalysis Today. 263 (2016) 117-122.

[27] R.D. Chambers et al., Elemental fluorine: Part 15. Selective direct fluorination of quinoline derivatives, J. Fluorine Chem. 125(5) (2004) 661-671.

[28] R. Jain et al., Synthesis of amino acid derivatives of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-substituted/4, 5-di substituted-quinolines as potential antimalarial agents, Ind. J. Chem. 33(3) (1994) 251-254.

[29] M. Croisy-Delcey et al., Diphenyl quinolines and isoquinolines: synthesis and primary biological evaluation, Bioorg. Med. Chem. 8(11) (2000) 2629-2641.

[30] B.N. Acharya, D. Thavaselvam, M.B. Kaushik, Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids, Med. Chem. Res. 17(8) (2008) 487-494.

[31] A.H. Abadi, R. Brun, Synthesis and evaluation of novel 7-trifluoromethyl-4-(4-substituted anilino)quinolines as antiparasitic and antineoplastic agents, Arzneimittelforschung Drug Research. 53(09) (2003) 655-663.

[32] R. Subashini, S. Mohana Roopan, F.N. Khan, Synthesis and free radical scavenging property of some quinoline derivatives, J. Chil. Chem. Soc. 55(3) (2010) 315-317.

[33] L. Hu et al., Design, Practical synthesis, and biological evaluation of novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic acid derivatives as HIV-1 integrase inhibitors, Molecules. 17(9) (2012) 10652-10666.

[34] N. Sun et al., Antibacterial activity of N-methylbenzofuro[3, 2-b]quinoline and N-methylbenzoindolo[3, 2-b]-quinoline derivatives and study of their mode of action, Eur. J. Med. Chem. 135 (2017) 1-11.

[35] J. A. Riddick, W. B. Bunger, T. Sakano, Organic solvents: physical properties and methods of purification, Techniques of Chemistry, New York, (1986).

[36] C. Perez, M. Pau, P. Bazerque, An antibiotic assay by agar well diffusion method, Acta Biol. Med. Exp. 1591) (1990) 113-115.

[37] S. Baluja, S. Chanda, Pyrazoline derivatives: Synthesis and antibacterial studies, World. Res. J. Biochem. 1(1) (2012) 6-10.